Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ronald Andrews

Ronald Andrews is recorded as CEO at Insight Molecular Diagnostics Inc. (IMDX). The proxy statement of Insight Molecular Diagnostics Inc. reports total compensation of $2,352,595 for Ronald Andrews in fiscal 2022, including a base salary of $459,692. Disclosed compensation is on record for 4 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Insight Molecular Diagnostics Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Insight Molecular Diagnostics Inc. (IMDX) $459,692 $2,352,595
2021 Insight Molecular Diagnostics Inc. (IMDX) $480,000 $2,921,838
2020 Insight Molecular Diagnostics Inc. (IMDX) $487,385 $1,046,850
2019 Insight Molecular Diagnostics Inc. (IMDX) $276,250 $2,065,962

Recent activity

No call appearances or filed executive changes recorded yet.